RxDoctor Payments Data

Charles Liu, PhD

Neurological Surgery · Los Angeles, CANPI 1568406080

Payments from drug & device makers

$8,811in general payments, 2019–2025

Across 35 payments — averaging $251.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Neuropace, Inc.$1K
  • Microtransponder, Inc.$806
  • Longeviti Neuro Solutions Inc$597
  • Livanova USA, Inc.$398
  • MML US, Inc.$210
  • plus $402 from 5 others

What the payments were for

  • Consulting fees$3,17536%
  • Speaking & faculty fees$2,00023%
  • Travel & lodging$7849%
  • Food & beverage$2,85232%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)5$5,133
Neuropace, Inc.8$1,266
Microtransponder, Inc.3$806
Longeviti Neuro Solutions Inc3$597
Livanova USA, Inc.8$398
MML US, Inc.3$210
Applied Medical Resources Corporation1$175
Boston Scientific1$169
Digital Surgery Systems, Inc.1$26
Globus Medical1$16
Urogen Pharma, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,811 in reported general payments places this provider in the 55th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California

Medicare billing

Part B allowed, 2024
$29,526
Medicare patients
123
Services billed
167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →